In recent years, GLP-1 receptor agonists have emerged as a powerful tool for improving metabolic health, gaining widespread attention for their ability to help reduce excess body fat
Top 10 products in this category
Rehfeld, Jan Fahrenkrug, Jens Holst, Thue Schwartz, Peter Horness, Claus Khl and Ove Schaffalitzky de Muckadell
Reduce guesswork by comparing serving sizes, bottle counts, and label notes in one place
Among these, 600mg of racemic ALA taken once daily is the most common and well-tolerated therapeutic dose, particularly for conditions like diabetic neuropathy
In 2025, the GLP-1 therapeutic category solidified its position as one of the most dynamic segments in the global health industry, driven by policy validation, strategic competition among major pharmaceutical players, and expanding indications beyond glycemic control, reports MBN